The Pharmaceutical industry in Gujarat ranks number one in India with a 33% share in drug manufacturing and a 28% share in drug exports. The state has 130 USFDA certified drug manufacturing facilities. [1] [2] Ahmedabad and Vadodara are considered as pharmaceutical hubs as there are many big and small pharma companies established in these cities. [3] [4]
Gujarat is one of the major states in India and has a significant presence in the pharmaceutical industry. The state is home to several large pharmaceutical companies: Sun Pharmaceuticals ,Cadila Pharmaceuticals, Torrent Pharmaceuticals, Alembic Pharmaceuticals, Intas Pharmaceuticals, Zydus Lifesciences, Amneal Pharmaceuticals, USV Pharmaceuticals, Baxter Healthcare and Outsuka Pharma more. [5] [6]
Gujarat has become a hub for the pharmaceutical industry, with several established companies such as Torrent Pharmaceuticals, Zydus Lifesciences, Cadila Pharmaceuticals, Alembic Pharmaceuticals, Sun Pharma, Claris, Intas Pharmaceuticals, and Dishman Pharmaceuticals having operations in the state. Gujarat currently has around 5000 drug manufacturing units and contributes 42 percent of India's pharmaceutical turnover and 22 percent of its exports as of 2008. [7] Over 52,000 individuals are employed in Gujarat's pharmaceutical sector, which has experienced a Compound Annual Growth Rate (CAGR) of 54 percent in capital investments over the last three years. [8] [9]
Gujarat's pharmaceutical industry holds a significant position in India, accounting for 40 percent of the country's total pharmaceutical production and 17 percent of its exports. The industry is valued at US$5.5 Billion.
During the 1940s and 50s, companies like The Gujarat Pharmaceutical and Chemical Works, Sarabhai Chemicals, Atul Products Ltd, Allied and Cadila Laboratories were established. [11]
Over the years, the pharmaceutical industry in Gujarat has grown significantly. The invested capital to labor ratio has risen significantly and the employment rate has almost doubled between 1979 and 1980 and 1997–98. There are currently around 3,500 drug manufacturing units in Gujarat, which employ over 52,000 individuals. [8]
Source: [28] [29] [8] | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Location | Ahmedabad | Vadodara | Ankleshwar | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Occupants |
|
|
|
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Types | Finished Dosages, Contract manufacturing | Finished Dosages, Biogenerics | APIs, Formulations, Vaccines | APIs, Finished Dosages | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Exports | High | High | Medium | Medium | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Market/ Resource/ Infrastructure-based | Market and Infrastructure-based | Market and Infrastructure-based | Resource-based | Resource-based |
Top 6 public pharmaceutical companies in Gujarat by market capitalization as of April 2023. [30]
Rank | Company | Location | Market capitalization (April 2023) | Ref(s) |
---|---|---|---|---|
1 | Torrent Pharmaceuticals | Ahmedabad | ₹534 billion (US$6.4 billion) | [31] |
2 | Zydus Lifesciences | Ahmedabad | ₹499 billion (US$6.0 billion) | [32] |
3 | Lupin | Ahmedabad | ₹299.67 billion (US$3.6 billion) | [33] |
4 | Alembic Pharmaceuticals | Vadodara | ₹108 billion (US$1.3 billion) | [34] |
5 | Eris Lifesciences | Ahmedabad | ₹100 billion (US$1.2 billion) | [35] |
6 | Dishman Carbogen Amcis | Ahmedabad | ₹80 billion (US$960 million) | [36] |
Top private pharmaceutical companies in India by reported valuation in 2022. [30]
Rank | Company | Location | Valuation (2022) |
---|---|---|---|
1 | Intas Pharmaceuticals | Ahmedabad | ₹593 billion (US$7.1 billion) |
2 | Cadila Pharmaceuticals | Ahmedabad | ₹70 billion (US$840 million) |
Multinational Pharmaceutical Companies ranked as per active presence of sales, marketing and business in India are as follows: [37]
The pharmaceutical sector in Gujarat has a significant focus on research and development (R&D), which has contributed to the growth of the industry in the state. The state government has been actively promoting R&D in the pharmaceutical sector and has established a number of initiatives to support this.
Gujarat FDCA (Food and Drugs Control Administration) Innovation and Research Cell, which was established to promote R&D in the pharmaceutical industry. The cell provides support for R&D activities and facilitates collaborations between the industry and academia. [38] [39] [40]
In addition, the state government has established the Gujarat Biotechnology Research Centre (GBRC) to promote biotechnology research in the state. The centre provides infrastructure and technical support to research institutions and companies in the biotechnology sector. [41] [42] [43]
The Gujarat government has also established several science and technology parks in the state, including the Gujarat Science City in Ahmedabad [44] and the Gujarat Biotech Park in Vadodara. These parks provide infrastructure and support services to companies engaged in R&D activities in various sectors, including pharmaceuticals. [45] [46]
Many of the leading pharmaceutical companies in Gujarat have their own R&D facilities and are actively engaged in the development of new products and technologies. For example, Zydus Lifesciences and Intas Pharmaceuticals one of the largest pharmaceutical companies in Gujarat, has a state-of-the-art R&D facility in Ahmedabad. [47] [48] Similarly, Torrent Pharmaceuticals has a dedicated R&D centre in Gandhinagar. [49] [50]
In addition to the initiatives and facilities mentioned earlier, the Gujarat government has also established the National Institute of Pharmaceutical Education and Research to promote R&D in the pharmaceutical sector. The centre provides infrastructure and technical support to pharmaceutical companies and research institutions in the state. It also facilitates collaborations between the industry and academia, and encourages the commercialization of R&D outcomes. [51]
The state government has also established a number of policies and incentives to promote R&D in the pharmaceutical sector. For example, the Gujarat Industrial Policy 2020 provides various incentives to companies engaged in R&D activities, including subsidies for the development of new products, tax exemptions on R&D expenditure, and funding for collaborations with academic institutions. [52] [53]
Gujarat government has taken the initiative to provide training in areas such as R&D, manufacturing, quality control, and regulatory affairs, and aims to develop a skilled workforce for the industry. [54]
the government initiatives, policies, and incentives have created an environment that promotes R&D in the pharmaceutical sector in Gujarat. This has led to the development of innovative products and technologies, which has helped to establish Gujarat as a hub for the pharmaceutical industry in India. [29]
Gujarat is one of the leading states in India in terms of pharmaceutical exports. The state has a well-established pharmaceutical industry with a strong focus on quality and innovation, which has helped it to become a major exporter of pharmaceutical products. According to the data from the Ministry of Commerce and Industry, Government of India, Gujarat was the second-largest exporter of pharmaceuticals in India during the fiscal year 2020–21, accounting for around 20% of the country's total pharmaceutical exports. [55] [56] [57] [58]
Pharmaceutical exports from Gujarat, India have increased by 11% in fiscal year 2018–19, according to data provided by the Gujarat State Board of Indian Drug Manufacturers’ Association (IDMA). Gujarat accounts for a minimum of 28% of India's pharma exports, with exports totalling $5.36bn in 2018–19, up from $4.83bn the previous year. The Indian pharma industry has bounced back with an estimated export value of $19.15bn in 2018–19, an increase of 10.85% over the previous year. The sector's strong performance is partly attributed to the strengthening of the dollar against the rupee. [59] [60] [61]
Gujarat's pharmaceutical exports consist of various types of products, including formulations, bulk drugs, intermediates, and drug formulations. The major markets for Gujarat's pharmaceutical exports are the United States, European Union, Africa, and the Middle East. [62] [63]
Year 2021–2022 [64] [65] | |||
Sr. No. | Districts | Commodities | Value of Export (in US$ Million) |
1 | Bharuch | Drugs And Pharmaceuticals | 406.06 |
Total export of District | 4695.14 | ||
2 | Ahmedabad | Drugs And Pharmaceuticals | 1218.54 |
Total export of District | 4439.12 | ||
3 | Vadodara | Drugs And Pharmaceuticals | 320.65 |
Total export of District | 3710.32 | ||
4 | Valsad | Drugs And Pharmaceuticals | 140.26 |
Total export of District | 1970.23 |
The Gujarat government has also taken several initiatives to promote pharmaceutical exports from the state. These initiatives include the establishment of pharma parks and special economic zones, providing financial incentives and subsidies for exporters, and the organization of trade fairs and exhibitions to showcase the products of the state's pharmaceutical industry. [66]
An industrial park, also known as industrial estate or trading estate, is an area zoned and planned for the purpose of industrial development. An industrial park can be thought of as a more heavyweight version of a business park or office park, which has offices and light industry, rather than heavy industry. Industrial parks are notable for being relatively simple to build; they often feature speedily erected single-space steel sheds, occasionally in bright colours.
Cipla Limited is an Indian multinational pharmaceutical company headquartered in Mumbai. Cipla primarily focuses on developing medication to treat respiratory disease, cardiovascular disease, arthritis, diabetes, depression, paediatric and various other medical conditions. Cipla has 47 manufacturing locations across the world and sells its products in 86 countries. It is the third-largest drug producer in India.
The pharmaceutical industry in India was valued at an estimated US$42 billion in 2021 and is estimated to reach $130 billion by 2030. India is the world's largest provider of generic medicines by volume, with a 20% share of total global pharmaceutical exports. It is also the largest vaccine supplier in the world by volume, accounting for more than 60% of all vaccines manufactured in the world. Indian pharmaceutical products are exported to various regulated markets including the US, UK, European Union and Canada.
Genome Valley is an Indian high-technology business district spread across 2,000-acre (8.1 km2)/(3.1 sq mi) in Hyderabad, India. It is located across the suburbs, Turakapally, Shamirpet, Medchal, Uppal, Patancheru, Jeedimetla, Gachibowli and Keesara. The Genome Valley has developed as a cluster for Biomedical research, training and manufacturing. Genome Valley is now into its Phase III, which is about 11 kms from the Phase I and II with the total area approximately 2,000-acre (8.1 km2).
Century Pharmaceuticals Ltd. is an Indian pharmaceutical company, founded in 1982 in Vadodara, Gujarat, India.
Ahmedabad is the industrial center in western India after Mumbai. The gross domestic product of Ahmedabad metro was estimated at US$136.1 billion in 2023. Ahmedabad is the largest contributor to the GDP of Gujarat state, with an estimated US$68 billion as of 2017 out of $227 billion, textile and clothing in Ahmedabad is one of the oldest industries. It is the largest supplier of denim and one of the largest exporters of gems and jewellery in the country. Ahmedabad has one of the largest concentration of pharmaceutical and biotech companies in India. Ahmedabad hosts the headquarters of major public-sector banks Ahmedabad Dist Co Op Bank, Ahd Mercantile Co-Op Bank Ltd, Ahmedabad Mercantil Co Op Bank, Dena Bank, The Cosmos Co - Op Bank, Manager Gujarat Ambuja Co-Operative, The Gujarat State Co-operative Bank Ltd.Gujarat State Coop Bank, The Kalupur Bank, Ahmedabad Capital Bank, Kutch Bank co op, Bank of Rajasthan, Bank of Marwad.
Teva Pharmaceutical Industries Ltd. is an Israeli multinational pharmaceutical company. Teva specializes primarily in generic drugs, but other business interests include branded-drugs, active pharmaceutical ingredients (APIs) and, to a lesser extent, contract manufacturing services and an out-licensing platform.
Torrent Pharmaceuticals Ltd is an Indian multinational pharmaceutical company, part of the Torrent Group and headquartered in Ahmedabad. It was promoted by U. N. Mehta, initially as Trinity Laboratories Ltd, and was later renamed Torrent Pharmaceuticals Ltd.
Zydus Lifesciences Limited, formerly known as Cadila Healthcare Limited, is an Indian multinational pharmaceutical company headquartered in Ahmedabad, which is primarily engaged in the manufacturing of generic drugs. The company ranked 100th in the Fortune India 500 list in 2020.
Sun Pharmaceutical Industries Limited is an Indian multinational pharmaceutical company headquartered in Mumbai, that manufactures and sells pharmaceutical formulations and active pharmaceutical ingredients (APIs) in more than 100 countries across the globe. It is the largest pharmaceutical company in India and the fourth largest specialty generic pharmaceutical company in the world. The products cater to a vast range of therapeutic segments covering psychiatry, anti-infectives, neurology, cardiology, diabetology, gastroenterology, ophthalmology, nephrology, urology, dermatology, gynecology, respiratory, oncology, dental and nutritionals.
The economy of Gujarat, a state in Western India, is the most industrialised in India, having the highest industrial output of any state in the union. It has the highest exports of any Indian state, accounting for 33% of all Indian exports in 2022–23. It leads in diverse industrial sectors such as chemicals, petrochemicals, dairy, drugs and pharmaceuticals, cement and ceramics, gems and jewellery, textiles and engineering. It has the highest Electricity Production Capacity and Maritime Port Cargo Volume among all states in India. It also has significant agricultural production with major agricultural produce of the state being cotton, groundnuts (peanuts), dates, sugar cane, milk and milk products. Gujarat recorded the lowest unemployment rate in India in 2022, with 4.4% of the labour force being unemployed.
Pankaj Ramanbhai Patel is an Indian billionaire businessman, and the chairman of Zydus Lifesciences, the fifth largest pharmaceutical company in India.
Lupin Limited is an Indian multinational pharmaceutical company based in Mumbai. It is one of the largest generic pharmaceutical companies by revenue globally. The company's key focus areas include paediatrics, cardiovascular, anti-infectives, diabetology, asthma and anti-tuberculosis.
Intas Pharmaceuticals Limited is an Indian multinational pharmaceutical company headquartered in Ahmedabad. It is a producer of generic therapeutic drugs and engaged in contract clinical research and manufacturing. It has 22 manufacturing plants, 17 in India and the rest in Greece, United Kingdom and Mexico. In the financial year 2019, 69% of the company's revenue came from international markets while 31% came from India. Its market presence is in more than 100+ countries.
Cadila Pharmaceuticals is an Indian multinational pharmaceutical company based in Ahmedabad. The company's operations focus on manufacturing products ranging from active pharmaceutical intermediates, finished formulations, food supplements, biotechnology products and pharmaceutical machinery.
Biotechnology in India is a sunrise sector within the Indian economy. Agencies of the Government of India concerned with the biotechnology industry include the Department of Biotechnology and the proposed Biotechnology Regulatory Authority of India. As of 2022, the sector is valued at $80 billion. Biotechnology in India is in a growth phase and the sector is expected to be valued at $150 billion by 2025 and surpass $300 billion in value by 2030.
ACG is a multinational pharmaceutical company with headquarters in Mumbai, India. The company has presence in over 100 countries on six continents. ACG is the world’s largest integrated supplier of solid dosage products and services. ACG provides empty hard pharmaceutical capsules, encapsulation machinery, tablet coating systems, tablet compression systems, fluid bed equipment, tablet tooling, and performance enhancers along with online and inline analytical and inspection systems. The company also provides blister packing, high barrier packaging films, carton packing machines, camera inspection systems, candy-wrapping machines, and end-of-line case packers. ACG has about 4,500 employees.
Alembic Pharmaceuticals Ltd. is an Indian multinational pharmaceutical company headquartered in Vadodara. It is involved in the manufacture of pharmaceutical products, pharmaceutical substances and intermediates. It is also termed to be a market leader in macrolides segment of anti-infective drugs in India.
Meril Life Sciences is an Indian multinational medical device company, with headquarters in Vapi, Gujarat, India. It was founded in 2006 and is a part of the Bilakhia Group. The company is engaged in the manufacturing of vascular intervention devices, orthopedic implants, endosurgery, ENT products and in-vitro diagnostics. Meril Life Sciences operates in over 100 countries and has employed 4000 people, as of 2022.
{{cite web}}
: CS1 maint: multiple names: authors list (link){{cite web}}
: |first=
has generic name (help){{cite web}}
: |last=
has generic name (help){{cite web}}
: CS1 maint: archived copy as title (link){{cite web}}
: |first=
has generic name (help)